{"id":223829,"date":"2023-06-23T00:00:00","date_gmt":"2023-06-23T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041093-medtech-enterprise-solutions-market-insights-europe\/"},"modified":"2026-03-31T10:12:23","modified_gmt":"2026-03-31T10:12:23","slug":"47041093-medtech-enterprise-solutions-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041093-medtech-enterprise-solutions-market-insights-europe\/","title":{"rendered":"Enterprise Solutions &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>The <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic has had a <span>negative<\/span> impact on the European enterprise solution market. However, following a period of recovery, the market will grow <span>strongly<\/span> through 2032, driven by the increasing movement toward improving market conditions, growing cybersecurity concerns, emerging legislative support, and the obsolescence of legacy healthcare IT infrastructure.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for enterprise solutions in Europe from 2019 through 2032.<\/p>\n<p><strong>The <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic had <span>negatively<\/span> impacted the Europe enterprise solution market.<\/strong><\/p>\n<p>How strongly has the enterprise solution market been impacted?<\/p>\n<p>At what pace is the enterprise solution market recovering?<\/p>\n<p class=\"question-statement\"><strong>Although <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> technology in Europe is highly regarded as a future keystone in healthcare IT structure, enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr> will continue to represent a large portion of the overall market.<\/strong><\/p>\n<p>What are the key differences between <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr>, and how do these differences contribute to the value proposition of each technology?<\/p>\n<p>How will the <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr> segments grow going forward? Which segment will be more dominant in the overall enterprise solutions market?<\/p>\n<p>What factors contribute to growth of the <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr> segments?<\/p>\n<p class=\"question-statement\"><b>Vendors of enterprise solutions must develop new competitive strategies to address the evolving purchasing priorities and needs of healthcare facilities.<\/b><\/p>\n<p>How will mergers and acquisitions change the competitive landscape of enterprise solutions?<\/p>\n<p>How will value-based healthcare and declining physician influence affect purchasing decisions for enterprise solution technologies?<\/p>\n<p>How must traditional <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr> vendors position themselves in a market that increasingly prioritizes vendor neutrality and interoperability between <abbr title=\"Health Care Information Technology\">HCIT<\/abbr> solutions?<\/p>\n<p>How will <abbr title=\"Artificial Intelligence\">AI<\/abbr> integration affect the competitiveness of certain companies?<\/p>\n<p>What tactics can dedicated image exchange solution vendors use to stay relevant in a market with rapidly changing preferences?<\/p>\n<p class=\"question-statement\"><strong>G<\/strong><b>overnment incentives for the adoption of digital health solutions, including <abbr title=\"Electronic Health Record\">EHR<\/abbr>,\u00a0will promote the adoption of enterprise solutions in the European market.\u00a0<\/b><\/p>\n<p>What are the key differences between the European and US markets for enterprise solutions?<\/p>\n<p>How will emerging government incentive programs shift purchasing priorities between <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr>, enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr>, and dedicated image exchange solutions?<\/p>\n<p>How will the direction of future government legislation affect the competitive dynamics within the market?<\/p>\n","protected":false},"template":"","class_list":["post-223829","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-enterprise-solutions","medtech-therapy-area-healthcare-it","medtech-geography-europe","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/223829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/223829\/revisions"}],"predecessor-version":[{"id":281635,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/223829\/revisions\/281635"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=223829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}